Singapore markets closed

Global Medical REIT Inc. (GMRE-PA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
24.85-0.00 (-0.00%)
At close: 02:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-0.60%
S&P500 52-week change 328.04%
52-week high 325.72
52-week low 323.32
50-day moving average 324.75
200-day moving average 324.75

Share statistics

Avg vol (3-month) 35.27k
Avg vol (10-day) 34.56k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 861.81M
% held by insiders 10.00%
% held by institutions 118.92%
Shares short (30 Apr 2024) 4649
Short ratio (30 Apr 2024) 40.01
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 4N/A
Shares short (prior month 28 Mar 2024) 4996

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 47.55%
Trailing annual dividend rate 30.84
Trailing annual dividend yield 33.38%
5-year average dividend yield 47.33
Payout ratio 4N/A
Dividend date 330 Apr 2024
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.82%
Operating margin (ttm)26.21%

Management effectiveness

Return on assets (ttm)1.77%
Return on equity (ttm)3.57%

Income statement

Revenue (ttm)139.94M
Revenue per share (ttm)2.13
Quarterly revenue growth (yoy)-3.10%
Gross profit (ttm)N/A
EBITDA 90.32M
Net income avi to common (ttm)14.91M
Diluted EPS (ttm)0.20
Quarterly earnings growth (yoy)5.70%

Balance sheet

Total cash (mrq)30.62M
Total cash per share (mrq)0.47
Total debt (mrq)625.6M
Total debt/equity (mrq)104.77%
Current ratio (mrq)1.96
Book value per share (mrq)7.62

Cash flow statement

Operating cash flow (ttm)66.96M
Levered free cash flow (ttm)81.66M